221 related articles for article (PubMed ID: 3081633)
41. Involvement of phospholipase A2 activation and arachidonic acid metabolism in the cytotoxic functions of rat NK cells.
Cifone MG; Botti D; Festuccia C; Napolitano T; del Grosso E; Cavallo G; Chessa MA; Santoni A
Cell Immunol; 1993 May; 148(2):247-58. PubMed ID: 8388321
[TBL] [Abstract][Full Text] [Related]
42. Identification of human natural killer soluble cytotoxic factors (NKCF) derived from NK-enriched lymphocyte populations: specificity of generation and killing.
Farram E; Targan SR
J Immunol; 1983 Mar; 130(3):1252-6. PubMed ID: 6822733
[TBL] [Abstract][Full Text] [Related]
43. Arachidonic acid metabolism of the murine eosinophil. II. Involvement of the lipoxygenase pathway in the response to the lymphokine eosinophil stimulation promoter.
Rand TH; Turk J; Maas RL; Colley DG
J Immunol; 1982 Sep; 129(3):1239-44. PubMed ID: 6286759
[TBL] [Abstract][Full Text] [Related]
44. Studies on the mechanism of natural killer cell-mediated cytotoxicity. VII. functional comparison of human natural killer cytotoxic factors with recombinant lymphotoxin and tumor necrosis factor.
Wright SC; Bonavida B
J Immunol; 1987 Mar; 138(6):1791-8. PubMed ID: 3493288
[TBL] [Abstract][Full Text] [Related]
45. Decreased natural killer activity in thalassemia major: a possible consequence of iron overload.
Akbar AN; Fitzgerald-Bocarsly PA; de Sousa M; Giardina PJ; Hilgartner MW; Grady RW
J Immunol; 1986 Mar; 136(5):1635-40. PubMed ID: 3005397
[TBL] [Abstract][Full Text] [Related]
46. Natural killer cell-mediated lysis involves an hydroxyl radical-dependent step.
Duwe AK; Werkmeister J; Roder JC; Lauzon R; Payne U
J Immunol; 1985 Apr; 134(4):2637-44. PubMed ID: 2982948
[TBL] [Abstract][Full Text] [Related]
47. Reversible inhibition of lymphokine-activated killer cell activity by lipoxygenase-pathway inhibitors.
Sibbitt WL; Imir T; Bankhurst AD
Int J Cancer; 1986 Oct; 38(4):517-21. PubMed ID: 3019899
[TBL] [Abstract][Full Text] [Related]
48. Induction of suppressor cells from peripheral blood T cells by 15-hydroperoxyeicosatetraenoic acid (15-HPETE).
Gualde N; Rigaud M; Goodwin JS
J Immunol; 1985 Nov; 135(5):3424-9. PubMed ID: 2931484
[TBL] [Abstract][Full Text] [Related]
49. Immunosuppressive effects of benzidine in mice: evidence of alterations in arachidonic acid metabolism.
Luster MI; Tucker AN; Hayes HT; Pung OJ; Burka T; McMillan R; Eling T
J Immunol; 1985 Oct; 135(4):2754-61. PubMed ID: 2993415
[TBL] [Abstract][Full Text] [Related]
50. Involvement of 5-lipoxygenase metabolites in ACTH-stimulated corticosteroidogenesis in rat adrenal glands.
Hirai A; Tahara K; Tamura Y; Saito H; Terano T; Yoshida S
Prostaglandins; 1985 Nov; 30(5):749-67. PubMed ID: 3001830
[TBL] [Abstract][Full Text] [Related]
51. Effects of various inhibitors of arachidonic acid oxygenation on macrophage superoxide release and tumoricidal activity.
Schultz RM; Nanda SK; Altom MG
J Immunol; 1985 Sep; 135(3):2040-4. PubMed ID: 2991375
[TBL] [Abstract][Full Text] [Related]
52. Leukotriene formation by a purified reticulocyte lipoxygenase enzyme. Conversion of arachidonic acid and 15-hydroperoxyeicosatetraenoic acid to 14, 15-leukotriene A4.
Bryant RW; Schewe T; Rapoport SM; Bailey JM
J Biol Chem; 1985 Mar; 260(6):3548-55. PubMed ID: 2982864
[TBL] [Abstract][Full Text] [Related]
53. Target cell-directed inactivation and IL-2-dependent reactivation of LAK cells.
Xiao J; Brahmi Z
Cell Immunol; 1989 Sep; 122(2):295-306. PubMed ID: 2788512
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of U937 eicosanoid and DNA synthesis by 5,8,11,14-eicosatetraynoic acid, an inhibitor of arachidonic acid metabolism and its partial reversal by leukotriene C4.
Ondrey F; Harris JE; Anderson KM
Cancer Res; 1989 Mar; 49(5):1138-42. PubMed ID: 2492901
[TBL] [Abstract][Full Text] [Related]
55. Fatty acid metabolism and cell proliferation. V. Evaluation of pathways for the generation of lipid peroxides.
Morisaki N; Lindsey JA; Stitts JM; Zhang H; Cornwell DG
Lipids; 1984 Jun; 19(6):381-94. PubMed ID: 6429469
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of cytotoxic T lymphocyte-mediated lysis by ETYA: effect independent of arachidonic acid metabolism.
Taylor AS; Howe RC; Morrison AR; Sprecher H; Russell JH
J Immunol; 1985 Feb; 134(2):1130-5. PubMed ID: 2981259
[TBL] [Abstract][Full Text] [Related]
57. Reactive oxygen species and not lipoxygenase products are required for mouse B-lymphocyte activation and differentiation.
Fedyk ER; Phipps RP
Int J Immunopharmacol; 1994 Jul; 16(7):533-46. PubMed ID: 7928003
[TBL] [Abstract][Full Text] [Related]
58. Effect of inhibitors of arachidonic acid metabolism on mitogenesis in human lymphocytes: possible role of thromboxanes and products of the lipoxygenase pathway.
Kelly JP; Johnson MC; Parker CW
J Immunol; 1979 Apr; 122(4):1563-71. PubMed ID: 109510
[TBL] [Abstract][Full Text] [Related]
59. Effect of lipoxygenase metabolites of arachidonic acid on proliferation of human T cells and T cell subsets.
Gualde N; Atluru D; Goodwin JS
J Immunol; 1985 Feb; 134(2):1125-9. PubMed ID: 2981258
[TBL] [Abstract][Full Text] [Related]
60. Transformation of 5-hydroperoxyeicosatetraenoic acid into dihydroxy- and cysteinyl-leukotrienes by rat hepatocytes: effects of glutathione.
Huwyler J; Bürgin M; Zeugin T; Gut J
Mol Pharmacol; 1991 Mar; 39(3):314-23. PubMed ID: 1848655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
